Tumors modulate fenestrated vascular beds and host endocrine status

Area of Science:

• Oncology
• Endocrinology
• Vascular Biology

Background:

• Preclinical cancer models (allograft/xenograft) are vital for studying tumor biology and treatment response.
• Current research often overlooks systemic toxicity and tumor-host interactions in treatment efficacy.
• The interplay between tumor growth and host physiology can significantly modulate therapeutic outcomes.

Purpose of the Study:

• To investigate the impact of tumor implantation and growth on host peripheral endocrine tissues.
• To explore potential mechanisms by which tumor-host interactions influence treatment response, particularly anti-angiogenic therapies.
• To understand the structural and functional vascular changes in endocrine tissues during tumor progression.

Main Methods:

• Implantation and growth of diverse human and mouse cell lines in mouse hosts.
• Analysis of structural and functional vascular changes in peripheral endocrine tissues.
• Investigation of host- and tumor-derived factors, including cytokines, growth factors, and myeloid-derived suppressor cells.
• Comparative analysis with the effects of exogenous estrogen administration.

Main Results:

• Tumorigenesis induced structural and potentially functional vascular alterations in peripheral endocrine tissues.
• These vascular changes may counteract fenestrated vessel attenuation caused by anti-angiogenic therapies.
• A multifactorial process involving cytokines, growth factors, and myeloid-derived suppressor cells is suggested.
• Exogenous estrogen administration elicited a structurally comparable vascular response.

Conclusions:

• Tumor growth significantly impacts host endocrine tissue vasculature, influencing systemic responses.
• These findings provide insights into clinical anti-angiogenic therapy adaptation.
• The observed phenomena may have implications for understanding cancer-cachexia and cancer-related anemia.